06 August 2020: Review Articles
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS)
Xiaochun Ma 1ABCDEF* , Menglin Liang 2B* , Min Ding 2B , Weiming Liu 2B , Huibo Ma 3BEF , Xiaoming Zhou 4ABE* , Hongsheng Ren 2ABE*DOI: 10.12659/MSM.925364
Med Sci Monit 2020; 26:e925364
Brief Introduction of 2019-nCoV
Burden and Challenges of Critical Illness with COVID-19
Basic Knowledge of ECMO
Evidence on ECMO Use in ARDS
Experience of ECMO in MERS and H1N1 Influenza
Technical Guidance and Recommendations On Use of ECMO in COVID-19 Patients
Current Situation of Use of ECMO in COVID-19 in China
Vital Questions of ECMO in COVID-19
Conclusions
References
Figure 1 (A) The modality of VV-ECMO. The most frequently used modality of VV-ECMO is to drain the venous blood out from the femoral vein and then infuse it back through the internal jugular vein, which not only eases the burden on the lung but also improves blood supply to the heart. (B) The modality of VA-ECMO. The traditional modality of VA-ECMO is to drain venous blood out from the femoral vein and then infuse it back through the femoral artery, which reduces the pulmonary workload and cardiac preload.